Eslicarbazepine-acetate

Eslicarbazepine acetate is the acetate ester of licarbazepine. An anticonvulsant, it is used as an adjunctive therapy for epilepsy by inhibiting repeated neuronal firing and stabilizing the inactivated state of voltage-gated sodium channels, thus preventing their return to the activated state during which seizure activity can occur. It is a dibenzoazepine, a carboxamide and a member of ureas.

General

Type : Drug, Pro-Drug, Benzazepin, Carbamate, Acetate, Carboxamide, Azepane

Chemical_Nomenclature : [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate

Canonical SMILES : CC(=O)OC1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N

InChI : InChI=1S\/C17H16N2O3\/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16\/h2-9,16H,10H2,1H3,(H2,18,21)\/t16-\/m0\/s1

InChIKey : QIALRBLEEWJACW-INIZCTEOSA-N

Other name(s) : Eslicarbazepine acetate  ||  BIA 2-093  ||  Aptiom  ||  Zebinix


MW : 296.32

Formula : C17H16N2O3

CAS_number : 236395-14-5

PubChem : 179344

UniChem : QIALRBLEEWJACW-INIZCTEOSA-N

Target

Structures : No structure

Families : Carb_B_Chordata, Arylacetamide_deacetylase

References (3)

Title : Role of human AADAC on hydrolysis of eslicarbazepine acetate and effects of AADAC genetic polymorphisms on hydrolase activity - Hirosawa_2021_Drug.Metab.Dispos__
Author(s) : Hirosawa K , Fukami T , Tashiro K , Sakai Y , Kisui F , Nakano M , Nakajima M
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , : , 2021
Abstract :
PubMedSearch : Hirosawa_2021_Drug.Metab.Dispos__
PubMedID: 33446525
Gene_locus related to this paper: human-AADAC

Title : Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers - Nunes_2013_Epilepsia_54_108
Author(s) : Nunes T , Rocha JF , Falcao A , Almeida L , Soares-da-Silva P
Ref : Epilepsia , 54 :108 , 2013
Abstract :
PubMedSearch : Nunes_2013_Epilepsia_54_108
PubMedID: 22812691
Gene_locus related to this paper: human-AADAC

Title : A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity - Shimizu_2012_Drug.Metab.Dispos_40_1183
Author(s) : Shimizu M , Fukami T , Kobayashi Y , Takamiya M , Aoki Y , Nakajima M , Yokoi T
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 40 :1183 , 2012
Abstract :
PubMedSearch : Shimizu_2012_Drug.Metab.Dispos_40_1183
PubMedID: 22415931
Gene_locus related to this paper: human-AADAC